PUBLISHER: Grand View Research | PRODUCT CODE: 1571420
PUBLISHER: Grand View Research | PRODUCT CODE: 1571420
The global colorectal surgery market size is anticipated to reach USD 36.6 billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of colorectal diseases, including colorectal cancer, inflammatory bowel disease (IBD), and diverticulitis, is a major driver. Colorectal cancer is one of the most common cancers globally, with the World Health Organization (WHO) reporting over 1.9 million new cases and nearly 1 million deaths in 2020. This high incidence creates a substantial demand for surgical interventions.
Technological advancements also play a crucial role. Innovations in minimally invasive surgical techniques, such as laparoscopic and robotic-assisted surgeries, have improved precision and patient outcomes, reducing recovery times and complications. The integration of advanced imaging technologies, like high-definition and 4K endoscopy, enhances diagnostic accuracy, further driving the adoption of these technologies.
Regulatory support and government initiatives are significant growth drivers as well. For example, the U.S. Preventive Services Task Force (USPSTF) recently lowered the recommended screening age for colorectal cancer to 45, increasing the demand for diagnostic and surgical procedures. Similarly, various European countries have implemented national screening programs that encourage early detection and treatment of colorectal cancer, supporting market expansion. Recent developments, such as the launch of AI-assisted endoscopy systems like Olympus' EVIS X1, are also enhancing market growth. These innovations offer real-time data and improved visualization, aiding in the early detection and treatment of colorectal conditions.